Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
US Army
Moodys
AstraZeneca
US Department of Justice
Baxter
Merck
Queensland Health
Colorcon
Boehringer Ingelheim

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,786,118

« Back to Dashboard

Which drugs does patent 7,786,118 protect, and when does it expire?

Patent 7,786,118 protects TEMODAR and is included in one NDA.

This patent has thirty-two patent family members in twenty-three countries.
Summary for Patent: 7,786,118
Title:Pharmaceutical formulations of antineoplastic agents
Abstract:In its several embodiments, this invention discloses a pharmaceutical formulation comprising at least one antineoplastic agent or a pharmaceutically acceptable salt thereof, and at least one dissolution enhancing agent sufficient to substantially dissolve said at least one antineoplastic agent in at least one aqueous diluent, wherein said dissolution enhancing agent is urea, L-histidine, L-threonine, L-asparagine, L-serine, L-glutamine or mixtures thereof; a lyophilized powder comprising said pharmaceutical formulation, and articles of manufacture thereof.
Inventor(s): Ugwu; Sydney (Gurnee, IL), Radhakrishnan; Vinay (Thousand Oaks, CA), Ihnat; Peter M. (Brooklyn, NY), Witchey-Lakshmanan; Leonore C. (Piscataway, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:12/403,113
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Drugs Protected by US Patent 7,786,118

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Merck Sharp Dohme TEMODAR temozolomide POWDER;INTRAVENOUS 022277-001 Feb 27, 2009 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,786,118

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,987,108 Pharmaceutical formulations of antineoplastic agents and processes of making and using the same ➤ Sign Up
8,623,868 Processes of making and using pharmaceutical formulations of antineoplastic agents ➤ Sign Up
7,674,790 Processes of making and using pharmaceutical formulations of antineoplastic agents ➤ Sign Up
8,076,335 Processes of making pharmaceutical formulations of antineoplastic agents ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,786,118

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway 20043961 ➤ Sign Up
Norway 335045 ➤ Sign Up
New Zealand 534378 ➤ Sign Up
South Korea 100970528 ➤ Sign Up
Mexico PA04008133 ➤ Sign Up
South Korea 20040085196 ➤ Sign Up
Japan 4785816 ➤ Sign Up
Japan 2008031186 ➤ Sign Up
Japan 4077794 ➤ Sign Up
Japan 2005518434 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Harvard Business School
Chubb
Fish and Richardson
UBS
Merck
Federal Trade Commission
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot